125 related articles for article (PubMed ID: 17455915)
1. Oxidative dehalogenation of perhalogenated benzenes by cytochrome P450 compound I.
Hackett JC; Sanan TT; Hadad CM
Biochemistry; 2007 May; 46(20):5924-40. PubMed ID: 17455915
[TBL] [Abstract][Full Text] [Related]
2. Mechanism and structure-reactivity relationships for aromatic hydroxylation by cytochrome P450.
Bathelt CM; Ridder L; Mulholland AJ; Harvey JN
Org Biomol Chem; 2004 Oct; 2(20):2998-3005. PubMed ID: 15480465
[TBL] [Abstract][Full Text] [Related]
3. Probing the Compound I-like reactivity of a bare high-valent oxo iron porphyrin complex: the oxidation of tertiary amines.
Chiavarino B; Cipollini R; Crestoni ME; Fornarini S; Lanucara F; Lapi A
J Am Chem Soc; 2008 Mar; 130(10):3208-17. PubMed ID: 18278912
[TBL] [Abstract][Full Text] [Related]
4. Aromatic hydroxylation by cytochrome P450: model calculations of mechanism and substituent effects.
Bathelt CM; Ridder L; Mulholland AJ; Harvey JN
J Am Chem Soc; 2003 Dec; 125(49):15004-5. PubMed ID: 14653732
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450-mediated oxidation of pentafluorophenol to tetrafluorobenzoquinone as the primary reaction product.
den Besten C; van Bladeren PJ; Duizer E; Vervoort J; Rietjens IM
Chem Res Toxicol; 1993; 6(5):674-80. PubMed ID: 8292746
[TBL] [Abstract][Full Text] [Related]
6. Prediction of activation energies for aromatic oxidation by cytochrome P450.
Rydberg P; Ryde U; Olsen L
J Phys Chem A; 2008 Dec; 112(50):13058-65. PubMed ID: 18986131
[TBL] [Abstract][Full Text] [Related]
7. Atmospheric oxidation of halogenated aromatics: comparative analysis of reaction mechanisms and reaction kinetics.
Kovacevic G; Sabljic A
Environ Sci Process Impacts; 2017 Mar; 19(3):357-369. PubMed ID: 28002503
[TBL] [Abstract][Full Text] [Related]
8. A predictive pattern of computed barriers for C-h hydroxylation by compound I of cytochrome p450.
de Visser SP; Kumar D; Cohen S; Shacham R; Shaik S
J Am Chem Soc; 2004 Jul; 126(27):8362-3. PubMed ID: 15237977
[TBL] [Abstract][Full Text] [Related]
9. Multistate reactivity in styrene epoxidation by compound I of cytochrome p450: mechanisms of products and side products formation.
Kumar D; de Visser SP; Shaik S
Chemistry; 2005 Apr; 11(9):2825-35. PubMed ID: 15744771
[TBL] [Abstract][Full Text] [Related]
10. How does the push/pull effect of the axial ligand influence the catalytic properties of Compound I of catalase and cytochrome P450?
Wang R; de Visser SP
J Inorg Biochem; 2007 Oct; 101(10):1464-72. PubMed ID: 17659781
[TBL] [Abstract][Full Text] [Related]
11. Theoretical and experimental studies of the conversion of chromopyrrolic acid to an antitumor derivative by cytochrome P450 StaP: the catalytic role of water molecules.
Wang Y; Chen H; Makino M; Shiro Y; Nagano S; Asamizu S; Onaka H; Shaik S
J Am Chem Soc; 2009 May; 131(19):6748-62. PubMed ID: 19385626
[TBL] [Abstract][Full Text] [Related]
12. Model electrochemical-mass spectrometric studies of the cytochrome P450-catalyzed oxidations of cyclic tertiary allylamines.
Jurva U; Bissel P; Isin EM; Igarashi K; Kuttab S; Castagnoli N
J Am Chem Soc; 2005 Sep; 127(35):12368-77. PubMed ID: 16131218
[TBL] [Abstract][Full Text] [Related]
13. A new hypothesis for the mechanism for cytochrome P-450 dependent aerobic conversion of hexahalogenated benzenes to pentahalogenated phenols.
Rietjens IM; Vervoort J
Chem Res Toxicol; 1992; 5(1):10-9. PubMed ID: 1581524
[TBL] [Abstract][Full Text] [Related]
14. Quantum chemical studies for oxidation of morpholine by Cytochrome P450.
Shaikh AR; Sahnoun R; Broclawik E; Koyama M; Tsuboi H; Hatakeyama N; Endou A; Takaba H; Kubo M; Del Carpio CA; Miyamoto A
J Inorg Biochem; 2009 Jan; 103(1):20-7. PubMed ID: 18848727
[TBL] [Abstract][Full Text] [Related]
15. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
de Visser SP; Tan LS
J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-catalyzed oxidation of halobenzene derivatives.
Rietjens IM; den Besten C; Hanzlik RP; van Bladeren PJ
Chem Res Toxicol; 1997 Jun; 10(6):629-35. PubMed ID: 9208168
[No Abstract] [Full Text] [Related]
17. Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450(cam)).
Jones JP; O'Hare EJ; Wong LL
Eur J Biochem; 2001 Mar; 268(5):1460-7. PubMed ID: 11231299
[TBL] [Abstract][Full Text] [Related]
18. The surprisingly facile thermal dehalogenation of chlorinated aromatics by a hydroaromatic donor solvent. Tautomerization of chlorinated phenols and anilines.
Mulder P; Arends IW; Santoro D; Korth HG
J Org Chem; 2003 May; 68(11):4247-57. PubMed ID: 12762723
[TBL] [Abstract][Full Text] [Related]
19. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation?
de Visser SP; Tahsini L; Nam W
Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895
[TBL] [Abstract][Full Text] [Related]
20. Studies on the cytochrome P450 catalyzed oxidation of 13C labeled 1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridine by 13C NMR.
Bissel P; Castagnoli N; Penich S
Bioorg Med Chem; 2005 Apr; 13(8):2975-80. PubMed ID: 15781407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
